產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-EFHD2抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-EFHD2抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-EFHD2
Cat. Number:
Anti-EFHD2抗體KL-14520R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
EFHD2 is a 240 amino acid protein that regulates spontaneous apoptosis through the regulation of Bcl-xS abundance. Localized to membrane raft, Swiprosin-1 is expressed in lymphocytes and contains two EF-hand domains. Anti-EFHD2抗體The gene encoding Swiprosin-1 maps to human chromosome 1, which spans 260 million base pairs, contains over 3,000 genes and comprises nearly 8% of the human genome. Chromosome 1 houses a large number of disease-associated genes, including those that are involved in familial adenomatous polyposis, Stickler syndrome, Parkinson’s disease, Gaucher disease, schizophrenia and Usher syndrome. Aberrations in chromosome 1 are found in a variety of cancers, including head and neck cancer, malignant melanoma and multiple myeloma.
Also known as:
EF hand domain containing protein 2;Anti-EFHD2抗體 EF hand domain family, member D2; EF-hand domain-containing protein D2; EFHD 2; EFHD2; EFHD2_HUMAN; RP3-467K16.3; Swiprosin 1; Swiprosin-1; SWS1.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Pig, Cow, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human EFHD2.
●
Predicted Molecular Weight: Anti-EFHD2抗體27kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-EFHD2抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-EFHD2抗體
Optimal working dilutions must be determined by the end user.
kl435Mu01 肌球蛋白ⅠF(MYO1F)多克隆抗體 Polyclonal Antibody to Myosin IF (MYO1F)
kl435Ra01 肌球蛋白ⅠF(MYO1F)多克隆抗體 Polyclonal Antibody to Myosin IF (MYO1F)
kl434Hu01 肌球蛋白ⅠE(MYO1E)多克隆抗體 Polyclonal Antibody to Myosin IE (MYO1E)
kl434Mu01 肌球蛋白ⅠE(MYO1E)多克隆抗體 Polyclonal Antibody to Myosin IE (MYO1E)
kl434Ra01 肌球蛋白ⅠE(MYO1E)多克隆抗體 Polyclonal Antibody to Myosin IE (MYO1E)
kl433Hu01 肌球蛋白ⅠD(MYO1D)多克隆抗體 Polyclonal Antibody to Myosin ID (MYO1D)
kl433Mu01 肌球蛋白ⅠD(MYO1D)多克隆抗體 Polyclonal Antibody to Myosin ID (MYO1D)
kl432Hu01 肌球蛋白ⅠC(MYO1C)多克隆抗體 Polyclonal Antibody to Myosin IC (MYO1C)
kl432Mu01 肌球蛋白ⅠC(MYO1C)多克隆抗體 Polyclonal Antibody to Myosin IC (MYO1C)
kl432Ra01 肌球蛋白ⅠC(MYO1C)多克隆抗體 Polyclonal Antibody to Myosin IC (MYO1C)
kl431Hu01 肌球蛋白ⅠB(MYO1B)多克隆抗體 Polyclonal Antibody to Myosin IB (MYO1B)
kl431Mu01 肌球蛋白ⅠB(MYO1B)多克隆抗體 Polyclonal Antibody to Myosin IB (MYO1B)
kl431Ra01 肌球蛋白ⅠB(MYO1B)多克隆抗體 Polyclonal Antibody to Myosin IB (MYO1B)
kl375Hu01 肌球蛋白ⅠA(MYO1A)多克隆抗體 Polyclonal Antibody to Myosin IA (MYO1A)
kl375Mu01 肌球蛋白ⅠA(MYO1A)多克隆抗體 Polyclonal Antibody to Myosin IA (MYO1A)
kl375Ra01 肌球蛋白ⅠA(MYO1A)多克隆抗體 Polyclonal Antibody to Myosin IA (MYO1A)
kl604Hu01 載脂蛋白A2(APOA2)多克隆抗體 Polyclonal Antibody to Apolipoprotein A2 (APOA2)
kl604Mu01 載脂蛋白A2(APOA2)多克隆抗體 Polyclonal Antibody to Apolipoprotein A2 (APOA2)
kl604Ra01 載脂蛋白A2(APOA2)多克隆抗體 Polyclonal Antibody to Apolipoprotein A2 (APOA2)
kl153Hu01 甲胎蛋白(αFP)多克隆抗體 Polyclonal Antibody to Alpha-Fetoprotein (aFP)
